Genomics in Cancer Care: Global Industry Outlook to 2028 Featuring Profiles of Key Players Including Illumina, Agilent Technologies, Roche Diagnostics, Cancer Genetics, and Bio-Rad Labs

Dublin, Jan. 26, 2024 (GLOBE NEWSWIRE) -- The "Genomics in Cancer Care Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028" report has been added to's offering.

With ongoing advancements and a new wave of innovation, the Global Genomics in Cancer Care Market is projected to experience noteworthy growth over the upcoming decade. This report examines the market's expansion, underpinned by the transformative impact of genomic technologies on cancer diagnosis and treatment.

The report delineates intricate details of the market dynamics, highlighting the surge in adoption of personalized medicine and cutting-edge genomic sequencing technologies. These elements are reshaping oncology paradigms and ushering in an era of precision cancer care, tailored to the genetic profiles of individual patients.

Driving Factors Behind Market Growth

The relentless pursuit of innovation in the personalized medicine space stands out as a prime catalyst for market proliferation. Tailored therapeutic regimens and the development of targeted therapies have the potential to not only fortify efficacy but also minimize adverse side effects associated with conventional treatments. This patient-centric model of healthcare embraces the complexity of the genetic underpinnings of cancer to optimize treatment approaches.

Advances in genomic sequencing, particularly the widespread implementation of Next-Generation Sequencing (NGS), are revolutionizing the industry by enabling a comprehensive analysis of cancer’s genetic fingerprint. Such insights are invaluable for crafting highly specific treatment pathways, leading to enriched clinical outcomes and the advancement of preventative cancer care strategies.

In the quest for more effective cancer therapeutics, drug development and research efforts are increasingly intertwined with genomics. The identification of new potential drug targets and the driving role of companion diagnostics further accentuates the growth of the Global Genomics in Cancer Care Market.

Emerging Trends and Innovations

Emergent technologies such as liquid biopsies are poised to redefine the landscape of cancer diagnostics and treatment monitoring. The utilization of single-cell genomics and the integration of multi-omic approaches promise to offer deeper insights into the complexity of cancer, paving the way for precision medicine and next-gen therapeutics.

Challenges to Market Growth

Despite this optimistic growth trajectory, challenges such as the high cost and accessibility of genomic testing, data privacy and security, interoperability, and the pressing need to address ethical and legal considerations persist. These challenges need to be strategically tackled to fully embrace the potential of genomics in the realm of cancer care.

Segmental and Regional Insights

The report provides a granular analysis of market segments, with a spotlight on Technology, Product, Application, End User markets, and more. It also sheds light on the regional market distributions, indicating that North America is predicted to maintain a commanding market presence due to its robust healthcare infrastructure, prolific cancer research initiatives, and the prevalence of major market incumbents.

Overall, the Global Genomics in Cancer Care Market is positioned at an exciting confluence of groundbreaking research and technological advancements that signal a promising horizon for market growth and the betterment of patient outcomes in cancer care.

A selection of companies mentioned in this report includes:

  • Illumina Inc.
  • Agilent Technologies, Inc.
  • Roche Diagnostics
  • Cancer Genetics, Inc.
  • Bio-Rad Laboratories Inc.
  • Sigma-Aldrich Corp.
  • GE Healthcare Inc.
  • Life Technologies Corp.
  • Quest Diagnostics Inc.

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


Contact Data